Case Report: Infection With SARS-CoV-2 in the Presence of High Levels of Vaccine-Induced Neutralizing Antibody Responses.

Schulte, Bianca; Marx, Benjamin; Korencak, Marek; Emmert, Dorian; Aldabbagh, Souhaib; Eis-Hübinger, Anna Maria; Streeck, Hendrik

Schulte, Bianca; Marx, Benjamin; Korencak, Marek; Emmert, Dorian; Aldabbagh, Souhaib; Eis-Hübinger, Anna Maria; Streeck, Hendrik.

Afiliação

Schulte B; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Marx B; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Korencak M; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Emmert D; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Aldabbagh S; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Eis-Hübinger AM; Institute for Virology, University Hospital Bonn, Bonn, Germany.
Streeck H; Institute for Virology, University Hospital Bonn, Bonn, Germany.

Front Med (Lausanne) ; 8: 704719, 2021.

Article em En | MEDLINE | ID: mdl-34368197

Palavras-chave

SARS-CoV-2; breakthrough infection; mRNA vaccines; neutralizing antibodies; virus variants

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google